Member Info for bogyo

I agree JHFH, I just dont want anyone thinking that Hemo is using their manpower breeding thousands of mice or that let other companies breed their mice for a 12% profit on the cost of the mice. It is all about the IP. IP of the mouse, and IP of whatever other Pharma companies develop from using the mice. Whatever ORGS will achieve in IP using our mice should leave Hemo with a 12% of the IP, and that is far bigger. That 12% is specific for ORGS and is different in every potential agreement moving forward.
I believe this company will value much higher than many would think of.

Does anyone honestly think they invested in a breeding farm for 12% cost of their mice...?
The mouse model serves as a unique platform for research. Anything comes out from such research should apply a 12% royalty on the IP.
Guys need to think more about how research really works and dont beg for updates every day on cash statements. For a long period it is not about generating cash. The important bit is what big names are behind it funding the research as these big names see where this is going on their investment. At the end the IP will potentially become a blockbuster sending the company to another level - therefore we have announced our Chairman`s CV yesterday supporting this.

SP Angel note is out, puts the RNS into a considerable nicer angle!
"
Sir Marc’s work in highlighting the role of tumor necrosis factor (TNF), a pro-inflammatory cytokine, in rheumatoid arthritis led to the development of antibody therapies such as Remicade (infliximab) which were both life-saving treatments and resulted in ‘blockbuster’ sales. This award is a demonstration of the expertise Hemogenyx can draw from as it continues to progress its own antibody-based programs. The Group is developing a bi-specific antibody, CDX, as a treatment for blood diseases as well as a neutralising antibody treatment against SARS-CoV-2, the causative virus of COVID-19 disease.

*SP Angel act as Joint Broker to Hemogenyx Pharmaceuticals"

yes quickdraw18, cytokine interpretation makes some sense in line with covid.
Hope the market wont take it as desperate but more like convincing.

I can read guys, and none of these tell me whats there to share from an investor perspective unless its really their policy. The chairmans cv is well known for the public and this rns should have zero effect on hemo sp.

I just wonder why did the company think this needs to be in an RNS? It is a nice appreciation and well done but what is the investor message here?

going for 5,76p hopefully just a wick. Still upside imo.

diluted. not a seller.

HavGD, you know this is not true we are going throigh this sensless rubbish with these two every day. I am happy to read you if you have any serious concerns of fundamentals or point to make why shorting at any point would make sense. Spamming others for your own greed to buy in at your lower target price is just twat.
But you probably have the time to read that all day and filter the rubbish in your mind. I dont.

So agree JW , those people puking their negativity for their own selfish reasons are just desperate spamming greedy twats, not worth anybody's time. I am only sorry for those who did not filter yet these two clowns here smokey1,2,3... and s7,8,9... and have to read their spams coming from their own complete senseless waste of life.
Glad to be here invested in this company and seeing one of the best researched board far from any others.
Fundamentals and analysis all points to a start of a new bullish cycle and an ATH on the shareprice.
Like to enjoy some positivity for once.
GLA

investing.com shows actual trade prices in live. While in here it is in 15min delay and shows you the bid/ask. These prices should then be reflected here in the trades tab.

this?
https://twitter.com/AntMwah/status/1272228329756770304?s=19
as soon as you sell it it will pump to 20p, thats why
no guarantee the gap at 4,6p will fill now. If it bounces off now as it can this will be bullish to test the previous top or beyond next.
up targets are significant to risk a sell and miss out the next move.

ontarget, the 0.618 fib is around 6,3p we broke that many times down. Going back above it would break all 1h ema and would be very bullish.
4h 200 ema- that looks a good support just now.

volume/value is pretty low on this share. therefore SP can be easily dragged along.
Not happy with the constant poke of the lower support.
As shared some time earlier it is probably hunting for liquidity and might break down to find it at lower levels before it heads up continuing with the impulse. Also there is that gap to close, which is usually hunted down.
Happy to keep it hold and maybe buying further at these lower prices.
There is no other way to interpret the news from yesterday that their research is continuing with success and this is great for the IP of the company. No need to mix it up with the ICL doing human trials - this is the job for Globalco to do, not Hemo. Globalco or any other Pharma will pump funds into the trials when the IP succeeds, and this is clearly the path here.

Testing is knowledge, data and is a safety measure for every future environment to come back to normality.
It is very simplistic to think that with a lower number of death under a partial lockdown condition the testing requirement will lower.
Testing is needed even to know that there are no new cases for long. You need to test multiple times millions to ensure safety for a longer period. And not talking about a pandemic without a working vaccine yet!
Currently new cases in UK is still in thousands every day.
This share will be huge and will be bursting at sales data in the next weeks.
These derampers are ****ing lucky to have the possibility to buy in at these depressed prices. So knowingly they are well arrogant about it.
109p gap closed today.
5 waves down in a falling wedge completed C correction.
I see this spiking anytime now and hope for a news drop to support it.
Dont like to engage into discussions with idioits with a clear motivation to downtalk a share.
Dyor. Imo.

This is a very simplistic view. There are plenty of huge supports on multiple level. 109p was the main gap target and it should not significantly drop lower.
Any authority aproval, order confirmation, distributor news will be sending this high above previous top.
Way undervalued still and huge potential here.
Clear buy for me.

Not sure why all the rumble about MMs manipulating the price to push through large buys. If so, then you guys are in good hands, as I guess all these large buyers will be holding for a greater return.
Upwards it will spike in a matter of time.

Chart was never lying, this was a top up since reached 7p. Under 7 is just a massive discount.
Grest news that all research they are doing is a success, most researxh fail at this stage.
Buy with two hands!
Imo, Dyor,

Anyone interested in the chart setup. Its the upside potential what matters and not to miss this buying opportunity.
https://twitter.com/AntMwah/status/1272228329756770304?s=19

Remember this below quote, and note the price in time? When rants give a trade advice selling at bottoms. They just pick every buy/topup opportunity to advise on selling. They never shout sell at the tops how traders make money.
Probably never heard of an ascending triangle formation.
Typical heard you can make money of.
"
S7eve083
Posted in: SEE
Posts: 1,767
Price: 2.35
Strong Sell
Profit warning20 May 2020 10:44
For those that missed it.
Biggest sell signal you'll ever find
"